SYT1 and Alzheimer disease: First, our findings are limited to the synergistic contribution of synaptic marker CSF GAP-43 abnormalities on Aβ-related tau accumulation, while CSF increases in numerous other synaptic markers have been reported previously in AD, including SNAP-25, synaptotagmin-1 or neurogranin25,47.